Charles River Laboratories International, Inc. (CRL) stock analysis

CRL · Charles River Laboratories International, Inc.

Latest recorded price: USD 335.63

Sector and industry: Healthcare · Diagnostics & Research

A reliable intrinsic value could not be calculated for CRL; the assessment relies on sector multiple comparisons. Fiscal 2025 figures: revenue growth 0.3%, free cash flow margin 12.9%, ROIC 0.4%. The model flags 1 risk signal for this company (1 high severity).

Similar companies in Healthcare